Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, June 16, 2023
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
Derik De Bruin Upgraded (WST) to Strong Buy and Increased Target to $405 on, Jun 16th, 2023
Derik De Bruin of B of A Securities, Upgraded "West Pharmaceutical Services, Inc." (WST) to Strong Buy and Increased Target from $390 to $405 on, Jun 16th, 2023.
Derik has made no other calls on WST in the last 4 months.
There are 2 other peers that have a rating on WST. Out of the 2 peers that are also analyzing WST, 0 agree with Derik's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Derik
- Jacob Johnson of "Stephens & Co." Upgraded from Hold to Buy and Increased Target to $400 on, Tuesday, April 11th, 2023
- Paul Knight of "Keybanc" Maintained at Buy with Increased Target to $375 on, Friday, February 17th, 2023
